Premium Company Profile Nastech Pharmaceutical

Publication Date	October 2007
Publisher	Datamonitor
Product Type	Report
Pages	56
ISBN Number	not applicable
Product Code	DAT08139

Price

£265.00
approximately: $495 | €336

PDF

PRINT £315 ($589 | €400)

Order above formats by FAX

Summary

Introduction

Nastech's goal is to become a leader in both the development and commercialization of innovative, nasal drug delivery products and technologies, as well as in RNAi therapeutics.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Nastech generates substantially all of its revenue from license and research fees. The company's total revenues increased at a CAGR of 34% during 2002-2006, from $9 million to $29 million.

Nastech's lead product candidate, Calcitonin-salmon, a natural peptide hormone produced by the thyroid gland that acts primarily on bone, is being developed for the treatment of osteoporosis and FDA review of ANDA is ongoing.

The company's biggest contributor to sales growth out to 2010 will be the royalty revenue stream. Revenues from royalties are expected to increase from $14 million in 2008 to $85 million in 2010. This represents an absolute growth of +$85 million, which is 72% of Nastech's total forecast growth.

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Overview
Catalyst
- Summary
- Company Structure
- Company Overview And Key Facts
- Business Description
- History
- Locations And Subsidiaries
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Products & Services
- Marketed Products
- Pipeline Products
- Historical Product Sales
- Ac Forecast Product Sales
- Competitors And Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- Swot Analysis
Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
Overview
- Discovery And Product Development
- Manufacturing
- Sales
- Scorecard
Overview
- Scorecard Analysis
- Key Employees
- List Of Key Employees
- Key Employee Biographies
- Financial And Operational Overview
- Financial And Operational Overview
- Key Industry Specific Ratios
Appendix
- Ask The Analyst
- Datamonitor Consulting
- Disclaimer
- Figure 1: Nastech - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: Nastech - Key Strategic Revenues, 2002-2006 ($ Mn)
- Figure 3: Nastech - Key Strategic Revenues, 2006-2010 ($ Mn)
- Table 1: Nastech - Key Facts
- Table 2: Nastech - Other Locations And Subsidiaries
- Table 3: Nastech - Year-End Share Price And Market Capitalization, 2002-2006 ($)
- Table 4: Nastech - Key Events Impacting Share Price Performance
- Table 5: Nastech - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 6: Nastech - Operating Cost Ratio Analysis, 2002-2006 (% Of Total Revenues)
- Table 7: Nastech - Balance Sheet, 2002-2006 ($ Mn)
- Table 8: Nastech - Cash Flow, 2002-2006 ($ Mn)
- Table 9: Nastech - Revenue Breakdown By Division, 2002-2006 ($ Mn)
- Table 10: Nastech - Marketed Products
- Table 11: Nastech - In-House Pipeline Products
- Table 12: Nastech - Collaboration Products
- Table 13: Nastech - Historical Product Sales, 2002-2006 ($ Mn)
- Table 14: Nastech - Forecast Sales, 2006-2010 ($ Mn)
- Table 15: Nastech - Key Competitors
- Table 16: Nastech - Key Suppliers
- Table 17: Nastech - Key Clients
- Table 18: Nastech - Key Shareholders
- Table 19: Swot Analysis Summary
- Table 20: Nastech - Value Chain Analysis
- Table 21: Nastech - Scorecard
- Table 22: Key Employees
- Table 23: Nastech - Financial And Operational Overview
- Table 24: Nastech - Key Industry Specific Ratios